acy of intermittent claudication by surgical intervention, supervised physical exercise training compared to no treatment
in unselected randomised patients I: one year results of functional and
physiological improvements. Eur J Vasc Endovasc Surg 2001;22:
107-13.
228. Koivunen K, Lukkarinen H. One-year prospective health-related
quality-of-life outcomes in patients treated with conservative
method, endovascular treatment or open surgery for symptomatic
lower limb atherosclerotic disease. Eur J Cardiovasc Nurs 2008;7:
247-56.
229. Mills JL. Infrainguinal disease: surgical treatment (Table 113-1). In:
Cronenwett JL, Johnston KW, editors. Rutherford’s Vascular Surgery. 8th edition. Philadelphia: Elsevier; 2014. p. 1768.
230. AbuRahma AF, Robinson PA, Holt SM. Prospective controlled study
of polytetraﬂuoroethylene versus saphenous vein in claudicant patients
with bilateral above knee femoropopliteal bypasses. Surgery
1999;126:594-601; discussion: 601-2.
231. Zannetti S, L’Italien GJ, Cambria RP. Functional outcome after
surgical treatment for intermittent claudication. J Vasc Surg 1996;24:
65-73.
232. Conte MS, Belkin M, Donaldson MC, Baum P, Mannick JA,
Whittemore AD. Femorotibial bypass for claudication: do results
justify an aggressive approach? J Vasc Surg 1995;21:873-80; discussion: 880-1.
233. Antoniou GA, Chalmers N, Georgiadis GS, Lazarides MK,
Antoniou SA, Serracino-Inglott F, et al. A meta-analysis of endovascular versus surgical reconstruction of femoropopliteal arterial disease.
J Vasc Surg 2013;57:242-53.
234. Ac